Product Program year 2022 Source: CMS Open Payments

BD Max

Device Molecular Diagnostics

PDI 30382904434206

Open in the dashboard

General payments

$30,272

530 payments

Research payments

$3,037,401

35 payments

Through program year 2022, $30,272 in general payments and $3,037,401 in research payments were reported against BD Max (Molecular Diagnostics).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2022 General $30,272 530
2022 Research $2,354,177 23
2021 Research $683,224 12

Breakdown

Who paid General payments · program year 2022
  1. Davol Inc. $29,616 502 payments
  2. Becton, Dickinson and Company $601 26 payments
  3. C. R. Bard, Inc. & Subsidiaries $32 1 payment
  4. Bard Peripheral Vascular, Inc. $23 1 payment
Top recipients General payments · program year 2022
  1. Randal Zhou Surgery · New Haven, CT $2,000 7% · 1 payment
  2. Artem Dyatlov Surgery · Bridgeport, CT $2,000 7% · 1 payment
  3. Joshua Davies Surgery · Boston, MA $2,000 7% · 1 payment
  4. David Lourie Surgery · Pasadena, CA $1,800 6% · 6 payments
  5. Heather Jolicoeur Physician Assistant · New Haven, CT $1,000 3% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2022.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2022
  1. Surgery $20,988 71% · 273 practitioners
  2. Nurse Practitioner, Family Nurse Practitioner $1,368 5% · 15 practitioners
  3. Physician Assistant $1,356 5% · 12 practitioners
  4. Physician Assistant, Surgical Physician Assistant $1,050 4% · 3 practitioners
  5. Physician Assistant, Medical Physician Assistant $1,034 3% · 3 practitioners

The top 5 of 44 specialties; each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2022
  1. Connecticut $5,033 17% · 5 recipients
  2. New Jersey $2,743 9% · 45 recipients
  3. California $2,537 8% · 23 recipients
  4. North Carolina $2,228 7% · 8 recipients
  5. Illinois $2,051 7% · 31 recipients

The top 5 of 39 states; each share is of general payments naming this product in 2022 where a state was reported.

The top 25 states, free in the app

530 general · 35 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record